Real-world Comparative Effectiveness of ARNI vs. ACEi/ARB in HF with Reduced/ Mildly Reduced EF

Clin Res Cardiol.

In this nationwide real-world study including a population of patients with HF with reduced or mildly reduced EF, ARNI as part of guideline-led Swedish clinical practice was associated with a statistically significant relative risk reduction in all-cause mortality compared with ACEi/ARB.